MINIPRESS PFIZER 437 (Minipress 2 mg)

Generic Name: prazosin

Pill imprint MINIPRESS PFIZER 437 has been identified as Minipress 2 mg.

Minipress is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome; heart failure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Minipress 2 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MINIPRESS PFIZER 437

Minipress 2 mg MINIPRESS PFIZER 437
Minipress
Generic Name:
prazosin
Imprint:
MINIPRESS
PFIZER 437
Strength:
2 mg
Color:
Pink & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00069-4370
Inactive Ingredients:
FD&C Blue No. 1
FD&C Red No. 3
D&C Red No. 28
FD&C Red No. 40
magnesium stearate
sodium lauryl sulfate
sucrose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-1290 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)